Risks of transfusion and organ and tissue transplantation: Practical concerns that drive practical policies

American Journal of Clinical Pathology

Volumn 107, Issue 4 SUPPL. 1, 1997, Pages

  DeChristopher, Phillip J ^a   Anderson, Richard R ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

Adverse effects; Blood transfusion; Donor; Risks; Tissue and organ transplantation

Indexed keywords

BIOCOMPATIBILITY; BLOOD BANK; BLOOD TRANSFUSION; DISEASE TRANSMISSION; FREQUENCY ANALYSIS; GRAFT SURVIVAL; HEMATOPOIETIC CELL; HUMAN; HUMAN CELL; ORGAN DONOR; ORGAN TRANSPLANTATION; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; SCREENING TEST; SEROLOGY; TISSUE TRANSPLANTATION; TISSUE TYPING;

BLOOD TRANSFUSION; COMMUNICABLE DISEASES; HEALTH POLICY; HISTOCOMPATIBILITY TESTING; HUMANS; ORGAN TRANSPLANTATION; POLICY MAKING; RISK FACTORS; TISSUE DONORS; TISSUE TRANSPLANTATION; UNITED STATES;

EID: 0030910455     PISSN: 00029173     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Centers for Disease Control and Prevention. Transmission of HIV through bone transplantation: Case report and public health recommendations. MMWR. 1988;37:597-599.
2. Marx RE, Carlson ER. Creutzfeldt-Jakob disease from allogeneic dura: a review of risks and safety. J Oral Maxillofac Surg. 1991;49:272-274.
3. Facts About Blood and Blood Banking. Rockville, Md: American Association of Blood Banks (text available over the Internet via WWW: http://www.aabb.org/docs/facts.html).
4. Klein HG (Chair). Standards for Blood Banks and Transfusion Services. 17th ed. Bethesda, Md: American Association of Blood Banks; 1996.
5. Linden JV, ed. Standards for Tissue Banking. McLean, Va: American Association of Tissue Banks; 1996.
6. Medical Standards of EBAA. Washington, DC: Eye Bank Association of America; 1994.
7. UNOS Articles of Incorporation, By-laws, and Policies. Richmond, Va: United Network for Organ Sharing; June 27, 1996.
8. Accreditation manual for organ procurement organizations. Falls Church, Va: Association of Organ Procurement Organizations; July 17, 1995.
9. DeChristopher PJ, Sosler SD. Discoveries and developments transforming blood banking and transfusion medicine: Part 2. Lab Med. 1995;26:315-321.
10. Vengelen-Tyler V (Chair), ed. Tissue banking and organ transplantation. In: Technical Manual. 12th ed. Bethesda, Md: American Association of Blood Banks; 1996:527-542.
11. Cunningham I. Allogeneic bone marrow transplantation. In: Hoffman R, Benz EJ Jr, Shattil SJ, Furie B, Cohen HJ, Silberstein LE, eds. Hematology: Basic Principles and Practice. 2nd ed. New York, NY: Churchill Livingstone, 1995:1387-1399.
12. Shulman IA and Petz LD. Red cell compatibility testing: Clinical significance and laboratory methods. In: Petz LD, Swisher SN, Kleinman S, et al, eds. Clinical Practice of Transfusion Medicine. 3rd ed. New York, NY: Churchill Livingstone. 1996;199-244.
13. Yowell RL, Araneo BA. Mechanisims of allograft rejection. In: Hammond EH, ed. Solid Organ Transplantation Pathology. Philadelphia, Pa. WB Saunders; 1994:4-18.
14. Ramsey G. Red cell antibodies arising from solid organ transplants. Transfusion. 1991;31:76-86.
15. Westphal RG, Carlson KB, Turc JM, eds. Emerging Global Patterns in Transfusion-transmitted Infection. Arlington, Va: American Association of Blood Banks; 1990.
16. Koff RS, Seeff LB, Dienstag JL. Transfusion-transmitted hepatitis A, B and D. In: Rossi EC, Simon TL, Moss GS, Gould SA, eds. Principles of Transfusion Medicine. 2nd ed. Baltimore, Md: Williams & Wilkins; 1996:675-745.
17. Goldman M, Blajchman MA. Bacterial contamination. In: Popovsky M, ed. Transfusion Reactions. Bethesda, Md: American Association of Blood Banks; 1996:125-165.
18. Schreiber GB, Busch MP, Kleinman S, et al. The risk of transfusion-transmitted viral infections. N Engl J Med. 1996;334:1685-1690.
19. Kakaiya R, Miller WV, Guding MD. Tissue transplant-transmitted infections. Transfusion. 1991;31:277-283.
20. Eastlund TD. Infectious disease transmission through tissue transplantation: Reducing the risk through donor selection. J Transplant Coordination. 1991;1:23-30.
21. Eastlund, TD. Infectious disease transmission through cell, tissue and organ transplantation: reducing the risk through donor selection. Cell Transplant. 1995;4:455-477.
22. Linden JV, Critser JK. Therapeutic insemination by donor II: a review of its known risks. Reprod Med Rev. 1995;4:19-29.
23. Centers for Disease Control and Prevention. Guidelines for preventing transmission of human immunodeficiency virus through transplantation of human tissues and organs. MMWR. 1994;43:1-17.
24. Pehta JC. Clinical studies with solvent detergent-treated products. Transf Med Rev. 1996;10:303-311.
25. Rossi EC, Simon TL, Moss GS, Gould SA, eds. Principles of Transfusion Medicine. 2nd ed. Baltimore, Md: Williams & Wilkins; 1996:747-811.
26. Davenport RD, Kunkel SL. Cytokine roles in hemolytic and nonhemolytic transfusion reactions. Transf Med Rev. 1994;8:157-168.
27. Ferrara JCM. The febrile platelet transfusion reaction: a cytokine shower. Transfusion. 1995;35:89-90. Editorial.
28. Przepiorka D, Leparc GF, Stovall MA, Werch J, Lichtiger B. Use of irradiated blood components. Am J Clin Pathol. 1996;106:6-11.
29. Kolbeck PC, Markin RS, McManus BM, eds. Transplant Pathology. Chicago, Ill: ASCP Press; 1994:300-307.
30. Klein HG. Immunomodulation caused by blood transfusion. In: Petz LD, Swisher SN, Kleinman S, et al, eds. Clinical Practice of Transfusion Medicine. 3rd ed. New York, NY: Churchill Livingstone; 1996:59-69.
31. Vamvakes EC. Transfusion-association cancer recurrence and postoperative infection: meta-analysis of randomized controlled clinical trials. Transfusion. 1996;36:175-186.
32. Harrington DS, Masih AS, Purtilo DT. Atypical immune proliferations. In: Hoffman R, Benz EJ, Jr, Shattil SJ, Furie B, Cohen HJ, Silberstein LE, eds. Hematology: Basic Principles and Practice. 2nd ed. New York, NY: Churchill Livingstone; 1995:1387-1399.
33. Purtilo DT, Harrington D. Malignant neoplasms in organ transplant recipients. In: Kolbeck PC, Markin RS, McManus BM, eds. Transplant Pathology. Chicago, Ill: ASCP Press; 1994:145-160.
34. Deeg HJ, Witherspoon RP. Risk factors for the development of secondary malignancies after marrow transplantation. In: Antin JH, Shulman LN, eds. Hematol Oncol Clin North Am: Therapy-related Second Malignancies. Philadelphia, Pa: WB Saunders; 1993;7:417-429.
35. Penn I. Tumors after renal and cardiac transplantation. In: Antin JH, Shulman LN, eds. Hematol Oncol Clin North Am: Therapy-related Second Malignancies. Philadelphia, Pa: WB Saunders; 1993;7:431-445.
36. Sazama K. Current good manufacturing practices. Transf Med Rev. 1996;10:286-295.
37. Public Health Service. Guideline on Infectious Diseases Issues in Xenotransplantation. 61 FR 49920; September 23, 1996. Draft.
38. Linden JV, Paul B, Dressler KP. A report of 104 transfusion errors in New York State. Transfusion. 1992;32:601-606.
39. Sazama K. Report of 355 transfusion-associated deaths: 1976-1985. Transfusion. 1990;30:583-590.